Alternatively, CAR targets against AML could involve antigens expressed on LB and LSC, entirely absent on CD34+ CD38− HSC/early progenitors, yet present on late hematopoietic progenitors and/or adult hematopoietic cells. This evidence concerns the gene CD38 and acute myeloid leukemia.